Pathstone Holdings, LLC

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 2011612 ENGLEWOOD, NJ

Position in BMRN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$530,600

+$21,061 QoQ

Shares Held

9,273

+2.8% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#338

of 561 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 56% Shared 0% None 44%

Healthcare · as of Jun 30, 2026

Pathstone Holdings, LLC holds $101,065,916 across 56 Biotechnology names. BMRN ranks #39 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,952	$22,825,735
2	REGN	Regeneron Pharmaceuticals, Inc.	13,825	$8,620,440
3	ASND	Ascendis Pharma A/S	20,248	$5,400,545
4	CYTK	Cytokinetics Inc	47,633	$4,057,854
5	JAZZ	Jazz Pharmaceuticals plc	15,152	$3,651,176
6	PTGX	Protagonist Therapeutics, Inc	28,187	$3,455,162
7	RPRX	Royalty Pharma plc	54,725	$3,068,429
8	ARGX	Argenx SE	3,094	$2,870,519

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$530,600	9,273	+2.8%	Shares	Sole	2026-08-13
2026-03-31	$509,539	9,020	-4.8%	Shares	Defined	2026-05-11
2025-12-31	$563,157	9,476	+15.6%	Shares	Defined	2026-02-13
2025-09-30	$443,841	8,195	-3.3%	Shares	Sole	2025-11-13
2025-06-30	$465,650	8,471	-14.9%	Shares	Sole	2025-08-12
2025-03-31	$703,293	9,949	+0.8%	Shares	Defined	2025-05-15
2024-12-31	$648,886	9,872	-0.4%	Shares	Sole	2025-02-14
2024-09-30	$696,643	9,911	0.0%	Shares	Sole	2024-11-07
2024-06-30	$815,972	9,911	+8.1%	Shares	Sole	2024-08-14
2024-03-31	$800,819	9,169	+25.4%	Shares	Sole	2024-05-13
2023-12-31	$705,215	7,314	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.